Task Sharing to Improve Post Abortion Care at District Health Care Level- Trial in Uganda
NCT01844024 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1010
Last updated 2014-08-29
Summary
Uganda is one of the countries with highest fertility rate in the world, 6.7 children per women. It is estimated that 56 percent of all pregnancies are unintended and the contraceptive prevalence rate in Uganda is 23 percent. Unwanted pregnancy is common and induced abortion is illegal. Unsafe abortion is responsible for significant morbidity and mortality among women in Uganda. Almost 40% of admissions to emergency obstetric care units in Uganda due to unsafe abortion is reported and considered high in international comparison. Studies have revealed that trained midlevel providers can deliver safe post abortion care (PAC) for incomplete abortion and use manual vacuum aspiration. The prostaglandin E1 analogue misoprostol has been shown to be an effective tool in the treatment of incomplete abortions. This option is so far under-used in developing countries, especially outside the larger hospitals and private clinics. One significant limiting factor in providing safe PAC is the lack of providers. So far technical training has been mainly limited to physicians. The long-term goal of this project is to provide evidence based information that will contribute to the development of strategies to increase women's access to high level post- abortion care at primary health care level provided by midlevel providers in Uganda. A task shift to midlevel provider in providing treatment of incomplete abortion will increase access to safe PAC and is a key to Millenium Development Goal 5. Misoprostol treatment of incomplete abortion remains underused and in accessible to a majority of women in Uganda because national regulations restricts its prescription and supervision to doctors. However, the safety of misoprostol treatment should make it amenable to provision by midlevel providers. Training of midlevel providers in misoprostol treatment of incomplete abortion will support task shifting in places where doctors are costly and scarce. By evaluating the effectiveness of mid-level providers (midwives); administering misoprostol treatment of incomplete abortion the project is attempting to contribute to the reduction of maternal mortality and morbidity and safeguard high quality of post-abortion care. A direct economic impact can also be expected due to reduced treatment costs of complications from unsafely induced abortion and incomplete abortions. The involvement of midlevel providers in medical treatment of incomplete abortion has previously not been systematically evaluated in African primary health care setting.
Conditions
- Pregnancy
Interventions
- OTHER
-
misoprostol by midwife
Women with incomplete abortion is diagnosed and treated with misoprostol by midwife
Sponsors & Collaborators
-
Makerere University
collaborator OTHER - lead OTHER
Principal Investigators
-
Josaphat Byamugisha, MD, PhD · Makerere University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 15 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-04-30
- Primary Completion
- 2014-07-31
- Completion
- 2014-07-31
Countries
- Uganda
Study Locations
More Related Trials
-
Post-abortion Care and Contraceptive Counselling by Midwives or Physicians
NCT01865136 ·Status: COMPLETED ·Phase: PHASE4
-
Mifepristone and Misoprostol for 2nd Trimester Termination of Pregnancy in Burkina Faso
NCT03269279 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparing Misoprostol and Oxytocin in UnijectTM for Postpartum Hemorrhage (PPH) Prevention in Mali
NCT01487278 ·Status: WITHDRAWN ·Phase: NA
-
Midlevel Versus Physician-provided Medical Abortion in the Second Trimester
NCT04181541 ·Status: COMPLETED ·Phase: NA
-
Misoprostol for the Treatment of Incomplete Abortion
NCT00670761 ·Status: COMPLETED ·Phase: NA
-
Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion
NCT00466999 ·Status: COMPLETED ·Phase: NA
-
A Study of Self-administered Misoprostol to Prevent Bleeding After Childbirth in the Community (MamaMiso)
NCT01510574 ·Status: COMPLETED ·Phase: NA
-
Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion in Nigeria
NCT01539408 ·Status: COMPLETED ·Phase: PHASE1
-
Vaginal Misoprostol In Management Of First Trimester Missed Abortion.
NCT03148314 ·Status: COMPLETED ·Phase: PHASE2
-
Mifepristone and Mid-Trimester Termination of Pregnancy
NCT00382538 ·Status: COMPLETED ·Phase: NA
-
Fertility and Obstetric Outcomes After Medical Management Versus Surgical Treatment for First-trimester Miscarriage First-trimester Miscarriage
NCT03570307 ·Status: UNKNOWN ·Phase: NA
-
Misoprostol in the Prevention of Postpartum Haemorrhage
NCT04044287 ·Status: UNKNOWN ·Phase: PHASE3
-
Misoprostol for Second Trimester Pregnancy Termination
NCT02669420 ·Status: COMPLETED ·Phase: PHASE2
-
Medical Termination of II Trimester Pregnancy
NCT03600857 ·Status: COMPLETED ·Phase: PHASE4
-
Cervical Preparation of Abortions Under Paracervical Block in the First Trimester:
NCT03043014 ·Status: COMPLETED ·Phase: NA
-
The Efficacy and Safety of Preoperative Misoprostol in Blood-loss Reduction During Myomectomy.
NCT03509168 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Mifepristone and Misoprostol for Midtrimester Termination of Pregnancy in Uzbekistan
NCT02235155 ·Status: COMPLETED
-
Two Different Regimens of Misoprostol in Retained Placenta
NCT02704780 ·Status: COMPLETED ·Phase: PHASE2
-
Misoprostol for the Treatment of Postpartum Hemorrhage
NCT00116350 ·Status: COMPLETED ·Phase: NA
-
Mifepristone Versus Misoprostol for Cervical Preparation Prior to Surgical Abortion Between 11 to 15 Weeks
NCT01636063 ·Status: TERMINATED ·Phase: NA
-
Study of Clinic-based vs. Self-use of a Misoprostol-only Regimen for Induced Abortion
NCT04242212 ·Status: UNKNOWN
-
Mifepristone Plus Misoprostol Versus Misoprostol Alone for 2nd Trimester Abortion (14 - 21 Weeks Last Menstrual Period (LMP))
NCT00969982 ·Status: COMPLETED ·Phase: NA
-
Medical Abortion for Emergency Contraception Failure
NCT00677755 ·Status: COMPLETED ·Phase: NA
-
Sublingual Misoprostol for the Treatment of Incomplete Abortion: Operations Research
NCT02707653 ·Status: COMPLETED ·Phase: NA
-
Optimal Treatment of Miscarriage
NCT01033903 ·Status: COMPLETED ·Phase: NA